Literature DB >> 33434210

Effect of intra-articular dexmedetomidine on experimental osteoarthritis in rats.

Lyvia Maria Rodrigues de Sousa Gomes1,2, Nicolau Gregori Czeczko3, Rayanne Luiza Tajra Mualem Araújo1, Maria do Socorro de Sousa Cartagenes1,2, José Osvaldo Barbosa Neto2, João Batista Santos Garcia1,2.   

Abstract

Pharmacological treatment of osteoarthritis is still inadequate due to the low efficacy of the drugs used. Dexmedetomidine via the intra-articular (i.a.) route might be an option for the treatment of osteoarthritis-associated pain. The present study assessed the analgesic and anti-inflammatory effects of dexmedetomidine administered via the i.a. route in different doses in an experimental model of rat knee osteoarthritis induced with monosodium iodoacetate. Rats were allocated to four groups with 24 animals in each group. The OA (osteoarthritis), DEX-1 (dexmedetomidine in dose of 1μg/kg) and DEX-3 (dexmedetomidine in dose of 3μg/kg) groups were subjected to induction of osteoarthritis through injection of monosodium iodoacetate (MIA) via the i.a. route on the right knee; the control group was not subjected to osteoarthritis induction. Clinical assessment was performed on day 0 (before osteoarthritis induction) and then on days 5, 10, 14, 21 and 28 after induction. Treatment was performed on day 7 via the i.a. route, consisting of dexmedetomidine in doses of 1 and 3 μg/kg, while group OA received 0.9% normal saline. The animals were euthanized on days 7, 14, 21 and 28. Samples of the synovial membrane were collected for histopathological analysis, and the popliteal lymph nodes were collected for measurement of cytokines (interleukin [IL] IL-6, tumor necrosis factor alpha [TNF-α]). Dexmedetomidine (1 and 3 μg/kg) significantly reduced the animals' weight distribution deficit during the chronic-degenerative stage of osteoarthritis and improved the pain threshold throughout the entire experiment. Histological analysis showed that dexmedetomidine did not cause any additional damage to the synovial membrane. The TNF-α levels decreased significantly in the DEX-3 group on day 28 compared with the OA group. Dexmedetomidine reduced pain, as evidenced by clinical parameters of osteoarthritis in rats, but did not have an anti-inflammatory effect on histological evaluation.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33434210      PMCID: PMC7802966          DOI: 10.1371/journal.pone.0245194

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  42 in total

1.  Pre-treatment with capsaicin in a rat osteoarthritis model reduces the symptoms of pain and bone damage induced by monosodium iodoacetate.

Authors:  Karel-Martijn Kalff; Mohammed El Mouedden; Jan van Egmond; Jan Veening; Leo Joosten; Gert Jan Scheffer; Theo Meert; Kris Vissers
Journal:  Eur J Pharmacol       Date:  2010-06-09       Impact factor: 4.432

2.  Locally injected dexmedetomidine inhibits carrageenin-induced inflammatory responses in the injected region.

Authors:  Shintaro Sukegawa; Hitoshi Higuchi; Miho Inoue; Hitoshi Nagatsuka; Shigeru Maeda; Takuya Miyawaki
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

3.  The alpha 2-adrenergic agonists clonidine and guanfacine produce tonic and phasic block of conduction in rat sciatic nerve fibers.

Authors:  J F Butterworth; G R Strichartz
Journal:  Anesth Analg       Date:  1993-02       Impact factor: 5.108

4.  Effect of Two Different Doses of Dexmedetomidine as Adjuvant in Bupivacaine Induced Subarachnoid Block for Elective Abdominal Hysterectomy Operations: A Prospective, Double-blind, Randomized Controlled Study.

Authors:  Anjan Das; Susanta Halder; Surajit Chattopadhyay; Parthajit Mandal; Subinay Chhaule; Rezina Banu
Journal:  Oman Med J       Date:  2015-07

Review 5.  Immune Cytokines and Their Receptors in Inflammatory Pain.

Authors:  Andrew D Cook; Anne D Christensen; Damini Tewari; Stephen B McMahon; John A Hamilton
Journal:  Trends Immunol       Date:  2018-01-12       Impact factor: 16.687

6.  Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis.

Authors:  Roberto E Guzman; Mark G Evans; Susan Bove; Brandy Morenko; Kenneth Kilgore
Journal:  Toxicol Pathol       Date:  2003 Nov-Dec       Impact factor: 1.902

7.  Dose-dependent expression of neuronal injury markers during experimental osteoarthritis induced by monoiodoacetate in the rat.

Authors:  Joana Ferreira-Gomes; Sara Adães; Raquel Meireles Sousa; Marcelo Mendonça; José Manuel Castro-Lopes
Journal:  Mol Pain       Date:  2012-07-08       Impact factor: 3.395

8.  Current concepts in osteoarthritis.

Authors:  Márcia Uchôa de Rezende; Gustavo Constantino de Campos; Alexandre Felício Pailo
Journal:  Acta Ortop Bras       Date:  2013-03       Impact factor: 0.513

Review 9.  The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.

Authors:  Piotr Wojdasiewicz; Łukasz A Poniatowski; Dariusz Szukiewicz
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

10.  Comparison of Efficacy of Intra-Articular Plain Bupivacaine and Bupivacaine with Adjuvants (Dexmedetomidine and Magnesium Sulfate) for Postoperative Analgesia in Arthroscopic Knee Surgeries: A Prospective, Randomized Controlled Trial.

Authors:  M Manjula Devi; Surbhi Gupta; Rajkumar Amaravathi; Sahana Udupa; Ajey Hegde; Santu Ghosh
Journal:  Anesth Essays Res       Date:  2018 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.